https://www.premera.com/medicalpolicies/5.01.564.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.564 Pharmacotherapy of Miscellaneous Autoimmune Diseases ... POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | CODING RELATED INFORMATION | EVIDENCE ...
https://www.premera.com/medicalpolicies/5.01.566.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.566 Pharmacotherapy of Thrombocytopenia Effective Date: ... POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | CODING RELATED INFORMATION | EVIDENCE ...
https://www.premera.com/medicalpolicies/5.01.582.pdf#search=policy
MEDICAL POLICY - 5.01.582 Antibody-Drug Conjugates Effective Date: April 1, 2024 Last ... below to be directed to that section. POLICY CRITERIA | CODING | RELATED INFORMATION ...
https://www.premera.com/medicalpolicies/5.01.587.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.587 Hereditary Angioedema Effective Date: May 1, 2023 ... below to be directed to that section. POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | ...
https://www.premera.com/medicalpolicies/5.01.591.pdf#search=policy
MEDICAL POLICY - 5.01.591 Immune Checkpoint Inhibitors Effective Date: May 1, 2024 Last ... POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | CODING RELATED INFORMATION | EVIDENCE ...
https://www.premera.com/medicalpolicies/5.01.595.pdf#search=policy
PHARMACY/MEDICAL POLICY - 5.01.595 Injectable Clostridial Collagenase for Fibroproliferative Disorders BCBSA Ref. Policy: 5.01.19 Effective Date: June 1, 2024 Last Revised: May ...
https://www.premera.com/medicalpolicies/5.01.613.pdf#search=policy
PHARMACY POLICY - 5.01.613 Oral Iron Chelating Agents Effective Date: April 1, 2024 Last ... below to be directed to that section. POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | ...
https://www.premera.com/medicalpolicies/7.01.07.pdf#search=policy
MEDICAL POLICY - 7.01.07 Electrical Bone Growth Stimulation of the Appendicular Skeleton BCBSA Ref. Policy: 7.01.07 Effective Date: July 1, 2024 Last Revised: June 10, 2024 ...
https://www.premera.com/medicalpolicies/7.01.137.pdf#search=policy
MEDICAL POLICY - 7.01.137 Magnetic Esophageal Sphincter Augmentation to Treat Gastroesophageal Reflux Disease BCBSA Ref. Policy: 7.01.137 Effective Date: Feb. 1, 2024 Last ...
https://www.premera.com/medicalpolicies/7.01.159.pdf#search=policy
MEDICAL POLICY - 7.01.159 Sphenopalatine Ganglion Block for Headache BCBSA Ref. Policy: 7.01.159 Effective Date: Feb. 1, 2024 Last Revised: Jan. 8, 2024 Replaces: N/A RELATED ...
https://www.premera.com/medicalpolicies/7.01.168.pdf#search=policy
MEDICAL POLICY - 7.01.168 Cryoablation, Radiofrequency Ablation, and Laser Ablation for Treatment of Chronic Rhinitis BCBSA Ref. Policy: 7.01.168 Effective Date: June 1, 2024 Last ...
https://www.premera.com/medicalpolicies/7.01.564.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.564 Pharmacotherapy of Miscellaneous Autoimmune Diseases ... POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | CODING RELATED INFORMATION | EVIDENCE ...
https://www.premera.com/medicalpolicies/7.01.567.pdf#search=policy
MEDICAL POLICY - 7.01.567 Surgical Treatments for Lymphedema and Lipedema BCBSA Ref. Policy: 7.01.162, 7.01.169, 7.01.173 Effective Date: Jan. 1, 2024 Last Revised: Dec. 11, 2023 ...
https://www.premera.com/medicalpolicies/8.01.62.pdf#search=policy
MEDICAL POLICY - 8.01.62 Electronic Brachytherapy for Nonmelanoma Skin Cancer BCBSA Ref. Policy: 8.01.62 Effective Date: Oct. 1, 2023 Last Revised: Sept. 11, 2023 Replaces: N/A ...
https://www.premera.com/medicalpolicies/1.01.525.pdf#search=policy
MEDICAL POLICY - 1.01.525 Postsurgical Home Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis BCBSA Ref. Policy: 1.01.28 Effective Date: June 1, 2024 Last ...
https://www.premera.com/medicalpolicies/2.02.16.pdf#search=policy
MEDICAL POLICY - 2.02.16 Ultrasonographic Measurement of Carotid Intimal-Medial Thickness as an Assessment of Subclinical Atherosclerosis BCBSA Ref. Policy: 2.02.16 Effective Date: ...
https://www.premera.com/medicalpolicies/2.02.18.pdf#search=policy
MEDICAL POLICY - 2.02.18 Progenitor Cell Therapy for the Treatment of Damaged Myocardium Due to Ischemia BCBSA Ref. Policy: 2.02.18 Effective Date: Aug. 1, 2023 Last Revised: July ...
https://www.premera.com/medicalpolicies/2.04.520.pdf#search=policy
MEDICAL POLICY - 2.04.520 Laboratory Testing Investigational Services BCBSA Ref. Policy: 2.04.159 Effective Date: Apr. 4, 2024 Last Revised: July 1, 2024 Replaces: N/A RELATED ...
https://www.premera.com/medicalpolicies/5.01.519.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.519 Increlex (mecasermin); Recombinant Human ... POLICY CRITERIA | CODING | RELATED INFORMATION EVIDENCE REVIEW | REFERENCES | HISTORY ∞ ...
https://www.premera.com/medicalpolicies/5.01.545.pdf#search=policy
PHARMACY POLICY - 5.01.545 Tadalafil Products for Benign Prostatic Hyperplasia Effective ... below to be directed to that section. POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | ...